Sanofi expects 2023 business EPS to grow low single digit at CER, barring unforeseen major adverse events. Applying average April 2023 exchange rates, the currency impact on 2023 business EPS is estimated between -5.5% to -6.5%.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on SNY:
- Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Provention
- ALX Oncology enters clinical trial collaboration with Sanofi
- SNY Upcoming Earnings Report: What to Expect?
- Sanofi announces launch of AVAXIM Junior in U.K.
- Sanofi price target raised to EUR 90 from EUR 85 at Deutsche Bank